News & Events
AccuGenomics and 1Cell.Ai Partner to Bring Ultra-Sensitive Liquid Biopsy Testing Across Asia, with Plans for U.S. Expansion
Collaboration integrates per-sample NGS internal standards with multi-omic precision oncology platform to enhance cancer diagnostics accuracy and access WILMINGTON, N.C. and MUMBAI, India, Oct. 13, 2025 /PRNewswire/ — AccuGenomics, Inc., a US-based leader in next-generation sequencing (NGS)
Join Us at SABCS – San Antonio, TX | December 9–12
Booth #1446 – Discover our latest breast cancer research and AI-driven insights shaping precision oncology. Plan Your Visit to SABCS
Join Us at World ADC – San Diego, CA | November 5–6
Booth #86 – See how 1Cell.Ai technology supports translational research and biomarker validation for next-generation ADC programs. Visit Us at World ADC
Join Us at ISLB 2025 – Orlando, FL | November 1–3
Booth #307 – Learn how live single circulating tumor cell capture is redefining biomarker discovery and precision oncology. Meet Us at ISLB
Join Us at ESMO 2025
Poster ePostersOur team will share new data across multiple tumor types using AI-powered single cell analysis. Explore Our Full Lineup at ESMO